Información del artículo
Pseudopheochromocytoma is a rare entity that has recently been defined. It occurs in patients with a clinical diagnosis of pheochromocytoma but without the typical medullary tumor; instead, they have an adrenal cortical adenoma or carcinoma. We report a patient with hypertension, elevated catecholamine levels and radiologic findings suggestive of pheochromocytoma. Pathological study was conclusive for adrenocortical adenoma. We review the literature on pseudopheochromocytoma, the usefulness of immunohistochemical markers in the study of adrenal tumors and discuss the neuroendocrine differentiation of adrenal cortical tumors.
Palabras clave:
Feocromocitoma
Neoplasia cortical suprarrenal
Diferenciación neuroendocrina
Inmunohistoquímica
Key words:
Pheochromocytoma
Adrenal cortical neoplasm
Neuroendocrine differentiation
Immunohistochemistry
El seudofeocromocitoma es una rara entidad recientemente definida. Ocurre en pacientes con el diagnóstico clínico de feocromocitoma pero sin el típico tumor medular suprarrenal, en lugar del que suele encontrarse un adenoma o un adenocarcinoma cortical suprarrenal. Describimos a una paciente con hipertensión arterial, hipersecreción de catecolaminas y hallazgos radiológicos compatibles con feocromocitoma, cuyo examen anatomopatológico fue concluyente de adenoma cortical. Revisamos la bibliografía referente al seudofeocromocitoma, la utilidad de los marcadores inmunohistoquímicos empleados en el estudio histopatológico de los tumores suprarrenales y, finalmente, se discute la patogenia de la diferenciación neuroendocrina de los tumores corticales.
El Texto completo está disponible en PDF
Biblografía
[1.]
R. Alsabeh, G. Mazoujian, J. Goates, L.J. Medeiros, L.M. Weiss.
Adrenal cortical tumors clinically mimicking pheochromocytoma.
Am J Clin Pathol, 104 (1995), pp. 382-390
[2.]
M. Sparagana, J.M. Feldman, Z. Molnar.
An unusual pheochromocytoma associated with an androgen secreting adrenocortical adenoma. Evaluation of its polypeptide hormone, catecholamine, and enzyme characteristics.
Cancer, 60 (1987), pp. 223-231
[3.]
L. García Pascual, J. Córdoba Cardona, R. Simó Canonge, J. Mesa Manteca, G. Obiols Alfonso, I. De Torres Ramírez.
Feocromocitoma clínicamente insospechado.
Rev Clin Esp, 189 (1991), pp. 227-230
[4.]
B. Castleman, V.W. Towne.
Case Records of the Massachusetts General Hospital. Case 42231.
N Engl J Med, 254 (1956), pp. 1090-1094
[5.]
G.A. Williams, C.h.L. Crockett, W.W.S. Butler, K.R. Crispell.
The coexistence of pheochromocytoma and adrenocortical hyperplasia.
J Clin Endocrinol Metab, 20 (1960), pp. 622-631
[6.]
C.R. Meloni, J. Tucci, J.J. Canary, L.H. Kyle.
Cushing's syndrome due to bilateral adrenocortical hyperplasia caused by a benign adrenal medullary tumor.
J Clin Endocr, 26 (1966), pp. 1192-1200
[7.]
R.F. Spark, P.B. Connolly, D.S. Gluckin, R. White, B. Sacks, L. Landsberg.
ACTH secretion from a functioning pheochromocytoma.
N Engl J Med, 310 (1979), pp. 416-418
[8.]
P.S. Dam, A. Van Gils, M.R. Canninga-van Dijk, E.J. De Koning, L.J. Hofland, W.W. De Herder.
Sequential ACTH and catecholamine secretion in a phaeochromocytoma.
Eur J Endocrinol, 147 (2002), pp. 201-206
[9.]
J.W. Goldzieher, H.E. McMahon, M.A. Goldzieher.
Coarctation of the abdominal aorta simulating pheochromocytoma.
Arch Int Med, 88 (1951), pp. 835-839
[10.]
C.h.H. Evans, V. Westfall, N.O. Atuk.
Astrocytoma mimicking the features of pheochromocytoma.
N Engl J Med, 286 (1972), pp. 1397-1399
[11.]
P.L. Robinson, E.T. Baker-Bates.
Adrenal cortical carcinoma simulating a phaeochromocytoma.
Br J Surg, 41 (1954), pp. 399-403
[12.]
G. Walters, G.B. Wyatt, J. Kelleher.
Carcinoma of the adrenal cortex presenting as a pheochromocitoma: report of a case.
J Clin Endocrinol, 22 (1962), pp. 575-580
[13.]
D.A. Mathison, C.A. Waterhouse.
Cushing's syndrome with hypertensive crisis and mixed adrenal cortical adenoma-pheochromocytoma (corticomedullary adenoma).
Am J Med, 47 (1969), pp. 635-641
[14.]
E. Van der Harst, W.W. De Herder, R.R. De Krijger, H.A. Bruining, H.J. Bonjer, S.W.J. Lamberts, et al.
The value of plasma markers for the clinical behaviour of phaechromocytoma.
Eur J Endocrinol, 147 (2002), pp. 85-94
[15.]
J.R. Crout, A. Sjoerdsma.
Turnover and metabolism of catecholamines in patients with pheochromocytoma.
J Clin Invest, 43 (1964), pp. 94-102
[16.]
I. Taubman, O.H. Paerson, A.H. Anton.
An asymptomatic catecholamine-secretingpheochromocytoma.
Am J Med, 57 (1974), pp. 953-956
[17.]
R. Udelsman, E.K. Fishman.
Radiology of the adrenal.
Endocrinol Metab Clin North Am, 29 (2000), pp. 27-42
[18.]
W.F. Young.
Management approaches to adrenal incidentalomas.
Endocrinol Metab Clin North Am, 29 (2000), pp. 159-185
[19.]
L. García Pascual, L. Gómez, S. Mañé Herrero, J. Anglada.
Doble falso negativo en la localización de un feocromocitoma.
Med Clin (Barc), 101 (1993), pp. 78
[20.]
B. Shapiro, L.M. Fig.
Management of pheochromocytoma.
Endocrinol Metab Clin North Am, 18 (1989), pp. 443-481
[21.]
W.F. Young.
Pheochromocytoma and primary aldosteronism: diagnostic approaches.
Endocrinol Metab Clin North Am, 26 (1997), pp. 801-827
[22.]
R.E. Scully, E.J. Mark, W.F. McNeely, B.U. McNeely.
Case records of the Massachusetts General Hospital. Case 46-1988.
N Engl J Med, 319 (1988), pp. 1336-1343
[23.]
M. Miettinen.
Neuroendocrine differentiation in adrenocortical carcinoma. New immunohistochemical findings supported by electron microscopy.
Lab Invest, 66 (1992), pp. 169-174
[24.]
S. Schröder, B.C.H. Padberg, E. Achilles, K. Holl, H. Dralle, G. Klöppel.
Immunocytochemistry in adrenocortical tumours: a clinicomorphological study of 72 neoplasms.
Virchows Archiv Pathol An, 420 (1992), pp. 65-70
[25.]
P. Komminoth, J. Roth, S. Scröder, P. Saremaslani, P.h. Heitz.
Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors.
Lab Invest, 72 (1995), pp. 424-431
[26.]
T.S. Loy, R.W. Philips, Ch.L. Linder.
A103 immunostaining in the diagnosis of adrenal cortical tumors. An immunohistochemical study of 316 cases.
Arch Pathol Lab Med, 126 (2002), pp. 170-172
[27.]
V.E. Gould, I. Lee, B. Wiedenmann, R. Moll, G. Chejfec, W.W. Franke.
Synaptophysin: a novel marker for neurons, certain neuroendocrine cells, and their neoplasms.
Human Pathol, 17 (1986), pp. 979-983
[28.]
B. Wiedenmann, W.B. Huttner.
Synaptophysin and chromogranins/ secretogranins. Widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis.
Virchows Archiv B Cell Pathol, 588 (1989), pp. 95-121
[29.]
L. Taupenot, K.L. Harper, D.T. O'Connor.
The chromogranin-secretogranin family.
N Engl J Med, 348 (2003), pp. 1134-1149
[30.]
H.R. Haak, G.J. Fleuren.
Neuroendocrine differentiation of adrenocortical tumors.
Cancer, 75 (1995), pp. 860-864
[31.]
L.J. Hoy, M. Emery, J.A. Wedzicha, et al.
Obstructive sleep apnea presenting as pseudopheochromocytoma: a case report.
J Clin Endocrinol Metab, 89 (2004), pp. 2033-2038
Copyright © 2004. Sociedad Española de Endocrinología y Nutrición
